Literature DB >> 24218143

Ectopic Cushing syndrome associated with thymic carcinoid tumor as the first presentation of MEN1 syndrome-report of a family with MEN1 gene mutation.

Shirin Hasani-Ranjbar1, Masoud Rahmanian, Azadeh Ebrahim-Habibi, Akbar Soltani, Akbar Soltanzade, Elnaz Mahrampour, Mahsa M Amoli.   

Abstract

Multiple endocrine neoplasia type 1(MEN1) is an autosomal dominant syndrome. Although thymic carcinoid tumor is recognized as a part of MEN1 syndrome but functioning thymic carcinoid tumor as the first presentation of the MEN1 seems to be very rare. In this report, we present a 29-year-old male who developed ectopic Cushing syndrome secondary to thymic carcinoid tumor and was diagnosed as MEN1 syndrome 2 years later. Further evaluation revealed the presence of carcinoid tumor and other MEN 1 manifestations in several other member of family. Genetic evaluation showed presence of a previously reported mutation in exon 10(R527X) of MEN1 gene in these patients. This presentation showed that thymic neuroendocrine tumor could be the first manifestation of the MEN1 syndrome and it might be diagnosed as a dominant manifestation of this syndrome in a family. We suggest biochemical or genetic screening for MEN-1 syndrome for patients with thymic carcinoid.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24218143     DOI: 10.1007/s10689-013-9692-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  20 in total

1.  A new frameshift MEN1 gene mutation associated with familial malignant insulinomas.

Authors:  Shirin Hasani-Ranjbar; Mahsa M Amoli; Azadeh Ebrahim-Habibi; Mohammad Hossein Gozashti; Nahid Khalili; Forugh A Sayyahpour; Jila Hafeziyeh; Akbar Soltani; Bagher Larijani
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.

Authors:  P Ferolla; A Falchetti; P Filosso; P Tomassetti; G Tamburrano; N Avenia; G Daddi; F Puma; R Ribacchi; F Santeusanio; G Angeletti; M L Brandi
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

3.  Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.

Authors:  Fathia Gibril; Yuan-Jia Chen; David S Schrump; Alexander Vortmeyer; Zhengping Zhuang; Irina A Lubensky; James C Reynolds; Adeline Louie; Laurence K Entsuah; Kane Huang; Behnam Asgharian; Robert T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

4.  Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1).

Authors:  N Hai; N Aoki; A Matsuda; T Mori; S Kosugi
Journal:  Eur J Endocrinol       Date:  1999-11       Impact factor: 6.664

Review 5.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

6.  Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1.

Authors:  Ali A Ghazi; Azizollah Abbasi Dezfooli; Farzaneh Mohamadi; Seyed Vahid Yousefi; Alireza Amirbaigloo; Siavash Ghazi; Marina Pourafkari; Dan Berney; Sian Ellard; Ashley B Grossman
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

7.  Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred.

Authors:  J R Burgess; J J Shepherd; V Parameswaran; L Hoffman; T M Greenaway
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

8.  Thymic carcinoids in multiple endocrine neoplasia type 1.

Authors:  B T Teh; J Zedenius; S Kytölä; B Skogseid; J Trotter; H Choplin; S Twigg; F Farnebo; S Giraud; D Cameron; B Robinson; A Calender; C Larsson; P Salmela
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

9.  Multiple endocrine neoplasia. Pituitary adenoma, multicentric papillary thyroid carcinoma, bilateral carotid body paraganglioma, parathyroid hyperplasia, gastric leiomyoma, and systemic amyloidosis.

Authors:  O Larraza-Hernandez; J Albores-Saavedra; G Benavides; L G Krause; J C Perez-Merizaldi; A Ginzo
Journal:  Am J Clin Pathol       Date:  1982-10       Impact factor: 2.493

Review 10.  Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.

Authors:  Manuel C Lemos; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

View more
  3 in total

1.  Clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients.

Authors:  Xiongfei Li; Mingbiao Li; Tao Shi; Renwang Liu; Dian Ren; Fan Yang; Sen Wei; Gang Chen; Jun Chen; Song Xu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 2.  Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Authors:  Fernando Guerrero-Pérez; Inmaculada Peiró; Agustina Pia Marengo; Alex Teulé; José Carlos Ruffinelli; Roger Llatjos; Teresa Serrano; Ivan Macia; Nuria Vilarrasa; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2021-05-07       Impact factor: 6.514

3.  Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome.

Authors:  Ieva Lase; Ieva Strele; Malin Grönberg; Gordana Kozlovacki; Staffan Welin; Eva Tiensuu Janson
Journal:  Hormones (Athens)       Date:  2020-01-16       Impact factor: 2.885

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.